Chemical Structure (Eplerenone 01)
Chemical structure of eplerenone, showing the arrangement of atoms and bonds in the molecule.*
Eplerenone
Product Images NDC 59762-1710
10 FDA label images from Mylan Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Eplerenone (NDC 59762-1710). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Eplerenone 02)
A line graph comparing cumulative incidence percentages over months since randomization between Eplerenone and placebo groups. The graph shows incidence increasing over time, with Eplerenone consistently lower than placebo. Risk numbers for each group are listed below the x-axis for intervals from 0 to 27 months.*
Figure 2 (Eplerenone 03)
A forest plot figure titled 'Hazard Ratios of All-Cause Mortality by Subgroups' showing hazard ratios with 95% confidence intervals for various patient subgroups in a study, including age groups, gender, race, diabetes status, hypertension, Killip class, creatinine clearance, and baseline use of medications such as beta blockers, ACE inhibitors, digoxin, and diuretics. The chart compares Eplerenone versus placebo with a hazard ratio scale from 0.0 to 2.0, where less than 1 favors Eplerenone and greater than 1 favors placebo.*
Figure 3 (Eplerenone 04)
A dose-response scatter plot showing the placebo-subtracted adjusted mean change from baseline in systolic blood pressure (SBP) with Eplerenone treatment in hypertension studies. The x-axis represents Eplerenone dose in mg/day (0 to 200), and the y-axis shows reduction in SBP in mm Hg (0 to 16). Data points are distinguished by study and dosing frequency: Study 1 QD (diamonds), Study 2 QD (circles), and Study 2 BID (squares).*
Figure 4 (Eplerenone 05)
A dose-response scatter plot graph showing the reduction in diastolic blood pressure (DBP) in mmHg on the y-axis versus daily Eplerenone dose in mg on the x-axis. The graph compares adjusted mean changes from baseline across different dosing regimens from multiple hypertension studies, indicated by symbols for Study 1 QD, Study 2 QD, and Study 2 BID.*
Greenstone Signature (Eplerenone 06)
Principal Display Panel (25 mg Tablet Bottle Label)
Packaging label for Eplerenone tablets, 25 mg strength, in a 30-tablet bottle. The label indicates it is a Greenstone® brand product with NDC 59762-1710-2. It includes storage instructions, dosage information advising to see accompanying prescribing information, and distribution by Greenstone LLC, Peapack, NJ. The label also features a barcode and lot/expiration information area.*
Principal Display Panel (25 mg Tablet Blister Pack)
The image shows a sheet of multiple labels for Eplerenone 25 mg tablets. Each label includes the drug name, strength (25 mg), dosage form (tablet), and manufacturer, identified as Greenstone LLC in Peapack, NJ 07977. The labels also feature barcodes, lot and expiration date areas, and the NDC number 13884600. The labeling is organized in a grid, with alternating orientations.*
Principal Display Panel (25 mg Tablet Blister Pack Carton)
Packaging label for Eplerenone tablets, 25 mg, Greenstone brand, distributed by Greenstone LLC. The label indicates a quantity of 100 tablets and is for in-institution use only. The label includes storage instructions at 25°C and notes to see accompanying prescribing information.*
Principal Display Panel (50 mg Tablet Bottle Label)
Label for Eplerenone tablets 50 mg, Greenstone brand, containing 30 tablets. Includes storage instructions to keep at 25°C with permitted excursions and a note to see prescribing information for dosage and use. Distributed by Greenstone LLC, Peapack, NJ.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
